Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome (Q37330330)

19 August 2017

Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome (English)

1 reference

19 August 2017

1 reference

Severin Kengne-Wafo

1

1 reference

19 August 2017

Laura Massella

2

1 reference

19 August 2017

Francesca Diomedi-Camassei

3

1 reference

19 August 2017

Alessandra Gianviti

4

1 reference

19 August 2017

Marina Vivarelli

5

1 reference

19 August 2017

Marcella Greco

6

1 reference

19 August 2017

Gilda Rita Stringini

7

1 reference

19 August 2017

Francesco Emma

8

1 reference

19 August 2017

23 July 2009

1 reference

Clinical Journal of the American Society of Nephrology

19 August 2017

1 reference

19 August 2017

4

1 reference

19 August 2017

9

1 reference

19 August 2017

1409-1416

1 reference

Uric acid: bystander or culprit in hypertension and progressive renal disease?

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Non-corticosteroid treatment for nephrotic syndrome in children

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Normotensive ischemic acute renal failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

A simple estimate of glomerular filtration rate in adolescent boys.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Cyclosporin in the treatment of idiopathic nephrotic syndrome in children.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736699

Long-term clinical and pathological effects of cyclosporin in children with nephrosis

2 September 2018

1 reference

12 December 2020

Proteinuria and immunity--an overstated relationship?

1 reference

12 December 2020

1 reference

12 December 2020

Renal handling of uric acid under cyclosporin A treatment

1 reference

12 December 2020

Cyclosporin therapy in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies

1 reference

12 December 2020

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

12 December 2020

Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats

1 reference

12 December 2020

Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis

1 reference

12 December 2020

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

12 December 2020

Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated

1 reference

12 December 2020

Association of cumulative cyclosporine dose with its irreversible nephrotoxicity in Japanese patients with pediatric-onset autoimmune diseases

1 reference

12 December 2020

Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.01520209

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19628686

1 reference